Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection.
Saved in:
| Title: | Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. |
|---|---|
| Authors: | Pascal KE; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;, Coleman CM; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201;, Mujica AO; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;, Kamat V; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;, Badithe A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;, Fairhurst J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;, Hunt C; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;, Strein J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;, Berrebi A; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201., Sisk JM; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201;, Matthews KL; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201;, Babb R; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;, Chen G; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;, Lai KM; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;, Huang TT; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;, Olson W; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;, Yancopoulos GD; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591; george@regeneron.com christos.kyratsous@regeneron.com., Stahl N; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;, Frieman MB; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201;, Kyratsous CA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591; george@regeneron.com christos.kyratsous@regeneron.com. |
| Source: | Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2015 Jul 14; Vol. 112 (28), pp. 8738-43. Date of Electronic Publication: 2015 Jun 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26124093 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pascal+KE%22">Pascal KE</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;<br /><searchLink fieldCode="AU" term="%22Coleman+CM%22">Coleman CM</searchLink>; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201;<br /><searchLink fieldCode="AU" term="%22Mujica+AO%22">Mujica AO</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;<br /><searchLink fieldCode="AU" term="%22Kamat+V%22">Kamat V</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;<br /><searchLink fieldCode="AU" term="%22Badithe+A%22">Badithe A</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;<br /><searchLink fieldCode="AU" term="%22Fairhurst+J%22">Fairhurst J</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;<br /><searchLink fieldCode="AU" term="%22Hunt+C%22">Hunt C</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;<br /><searchLink fieldCode="AU" term="%22Strein+J%22">Strein J</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;<br /><searchLink fieldCode="AU" term="%22Berrebi+A%22">Berrebi A</searchLink>; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201.<br /><searchLink fieldCode="AU" term="%22Sisk+JM%22">Sisk JM</searchLink>; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201;<br /><searchLink fieldCode="AU" term="%22Matthews+KL%22">Matthews KL</searchLink>; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201;<br /><searchLink fieldCode="AU" term="%22Babb+R%22">Babb R</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;<br /><searchLink fieldCode="AU" term="%22Chen+G%22">Chen G</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;<br /><searchLink fieldCode="AU" term="%22Lai+KM%22">Lai KM</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;<br /><searchLink fieldCode="AU" term="%22Huang+TT%22">Huang TT</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;<br /><searchLink fieldCode="AU" term="%22Olson+W%22">Olson W</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;<br /><searchLink fieldCode="AU" term="%22Yancopoulos+GD%22">Yancopoulos GD</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591; george@regeneron.com christos.kyratsous@regeneron.com.<br /><searchLink fieldCode="AU" term="%22Stahl+N%22">Stahl N</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591;<br /><searchLink fieldCode="AU" term="%22Frieman+MB%22">Frieman MB</searchLink>; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201;<br /><searchLink fieldCode="AU" term="%22Kyratsous+CA%22">Kyratsous CA</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591; george@regeneron.com christos.kyratsous@regeneron.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227505876%22">Proceedings of the National Academy of Sciences of the United States of America</searchLink> [Proc Natl Acad Sci U S A] 2015 Jul 14; Vol. 112 (28), pp. 8738-43. <i>Date of Electronic Publication: </i>2015 Jun 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22National+Academy+of+Sciences%22">National Academy of Sciences </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7505876 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1091-6490 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200278424%22">00278424 </searchLink><i>NLM ISO Abbreviation: </i>Proc Natl Acad Sci U S A <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26124093 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1073/pnas.1510830112 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 8738 Titles: – TitleFull: Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pascal KE – PersonEntity: Name: NameFull: Coleman CM – PersonEntity: Name: NameFull: Mujica AO – PersonEntity: Name: NameFull: Kamat V – PersonEntity: Name: NameFull: Badithe A – PersonEntity: Name: NameFull: Fairhurst J – PersonEntity: Name: NameFull: Hunt C – PersonEntity: Name: NameFull: Strein J – PersonEntity: Name: NameFull: Berrebi A – PersonEntity: Name: NameFull: Sisk JM – PersonEntity: Name: NameFull: Matthews KL – PersonEntity: Name: NameFull: Babb R – PersonEntity: Name: NameFull: Chen G – PersonEntity: Name: NameFull: Lai KM – PersonEntity: Name: NameFull: Huang TT – PersonEntity: Name: NameFull: Olson W – PersonEntity: Name: NameFull: Yancopoulos GD – PersonEntity: Name: NameFull: Stahl N – PersonEntity: Name: NameFull: Frieman MB – PersonEntity: Name: NameFull: Kyratsous CA IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 07 Text: 2015 Jul 14 Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 1091-6490 Numbering: – Type: volume Value: 112 – Type: issue Value: 28 Titles: – TitleFull: Proceedings of the National Academy of Sciences of the United States of America Type: main |
| ResultId | 1 |